---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-001306"
form_type: "8-K"
ticker: "HLF"
cik: "0001180262"
company_name: "HERBALIFE LTD."
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T14:55:24.313367+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Herbalife Q3 net sales down 6% to $1.4B; adjusted EPS and EBITDA beat high-end guidance

## Summary
- Net sales of $1.4B, down 6% YoY; reported diluted EPS $1.09, adjusted diluted EPS $1.21, both up ~5% YoY.
- Adjusted EBITDA of $222.4M; adjusted EPS and EBITDA exceeded high end of guidance ranges.
- Reiterated FY2021 outlook: net sales growth 4.5%–8.5%, adjusted EPS $4.55–$4.95, adjusted EBITDA $860M–$910M.
- Repurchased 3.5M shares for $162M in Q3; sales leaders active up 10% YoY ex-China.
- Asia Pacific net sales +11% (India +46%, 5th straight record); N.America two-year stack +38% vs Q3 2019.

## SEC filing metadata
- accession: 0001157523-21-001306
- form_type: 8-K
- ticker: HLF
- cik: 0001180262
- company_name: HERBALIFE LTD.
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1180262/000115752321001306/0001157523-21-001306-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1180262/000115752321001306/a52519635.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-001306
- JSON: https://secwatch.observer/filing/0001157523-21-001306.json
- Plain text: https://secwatch.observer/filing/0001157523-21-001306.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.